Ligand validation:3VD9

IPT: 1-methylethyl 1-thio-beta-D-galactopyranoside

IPT is a Ligand Of Interest in 3VD9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VD9_IPT_A_2001	79%	50%	0.115	0.961	0.48	1.41	-	1	0	0	100%	0.95
3VD9_IPT_B_2001	78%	45%	0.11	0.951	0.59	1.51	-	1	0	0	100%	1
3VD9_IPT_D_2001	77%	47%	0.106	0.945	0.54	1.49	-	1	0	0	100%	0.96
3VD9_IPT_C_2001	77%	47%	0.112	0.95	0.56	1.45	-	1	0	0	100%	1
1PX4_IPT_C_2001	95%	49%	0.072	0.975	0.61	1.35	-	3	0	0	100%	1
1JYX_IPT_D_2001	94%	38%	0.074	0.974	0.43	1.97	-	5	0	0	100%	0.96
3DYO_IPT_C_2001	90%	47%	0.085	0.969	0.68	1.36	-	3	0	0	100%	1
3T0B_IPT_B_2001	89%	41%	0.087	0.965	0.52	1.74	-	2	0	0	100%	1
3T08_IPT_B_2001	88%	60%	0.086	0.962	0.57	0.94	-	-	0	0	100%	1
2P9H_IPT_A_998	90%	30%	0.098	0.981	1.39	1.39	1	2	0	0	100%	1
4OUE_IPT_A_502	88%	36%	0.107	0.984	1.4	1.14	1	1	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.